Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAAE for Resistant Hypertension
NCT05552300Unknown
- Sponsor
- The First Affiliated Hospital of Chengdu Medical College
- Start
- Oct 2022
- Primary completion
- Oct 2024
01
Overview
Randomised, open-label trial in resistant hypertension (RH) (2 arms), sponsored by The First Affiliated Hospital of Chengdu Medical College. Primary endpoint: Change of 24-h average systolic blood pressure at 6 months. Status: unknown.
02
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT05552300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05552300.